Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 259

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 259
---
Co Common Stock.

#### Required Vote for Approval
The approval of the Nasdaq Proposal requires the affirmative vote of a majority of the votes cast by stockholders present in person or represented by proxy and entitled to vote thereon at the Special Meeting (which would include presence by virtual attendance at the Special Meeting). An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as we believe the Nasdaq Proposal will be considered as non-discretionary) nor count as a vote cast in the Special Meeting.

The Nasdaq Proposal is conditioned on the approval and adoption of each of the Business Combination Proposal, the Incentive Plan Proposal, and the Election of the Directors Proposal.

#### Recommendation of the Iris Board

### THE IRIS BOARD UNANIMOUSLY RECOMMENDS THAT IRIS STOCKHOLDERS

#### VOTE “FOR” THE APPROVAL OF THE NASDAQ PROPOSAL.
<div align='center'>125</div>

TABLE OF CONTENTS

<div align='center'>**PROPOSAL NO. 3 — THE EQUITY INCENTIVE PLAN PROPOSAL**</div>

We are submitting for the approval of Iris’s stockholders, the ParentCo 2024 Omnibus Equity and Incentive Plan, or Incentive Plan. The Incentive Plan will become effective upon the closing of the Business Combination and is a comprehensive incentive compensation plan under which ParentCo can grant equity-based and other incentive awards to officers, employees, directors, consultants and advisers to, ParentCo and its subsidiaries. The purpose of the Incentive Plan is to help us attract, motivate and retain such persons with awards designed for the U.S. market and thereby enhance stockholder value.

Administration . Upon effectiveness, the Incentive Plan will be administered by a committee designated by the ParentCo Board (“Plan Committee”). The Plan Committee will have the power to determine, among other items, the terms of the awards granted under the Incentive Plan, including the exercise price, the number of shares subject to each award (and the class of shares), and the exercisability and vesting terms of the awards. The Plan Committee also will have the power to determine the persons to whom and the time or times at which awards will be made and to make all other determinations and take all other actions advisable for the administration of the Incentive Plan. All decisions made by the Plan Committee pursuant